Related Experiment Video

Updated: Feb 28, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.5K

Metabolic complications of antiretroviral therapy in children

Ethan G Leonard1, Grace A McComsey

  • 1Division of Pediatric Infectious Diseases, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.

The Pediatric Infectious Disease Journal
|January 25, 2003
PubMed

Insights

Highly active antiretroviral therapy improves survival for children with HIV. However, this review covers metabolic complications like lipodystrophy and growth failure in these young patients.

Area of Science:

  • Pediatric infectious diseases
  • Pediatric endocrinology
  • Clinical pharmacology

Background:

  • Highly active antiretroviral therapy (HAART) has dramatically improved survival rates for children with HIV.
  • Children may experience greater vulnerability to HAART-related metabolic side effects due to growth impacts and cumulative exposure.
  • Metabolic complications pose significant challenges to long-term health in pediatric HIV management.

Purpose of the Study:

  • To review the epidemiology and management of metabolic complications in HIV-infected children.
  • To highlight the specific challenges faced by children regarding these side effects.
  • To provide an overview of current understanding and strategies for managing these conditions.

Main Methods:

  • Literature review of studies on metabolic side effects in HIV-infected children.
  • Synthesis of data on the incidence and clinical presentation of various complications.
  • Summary of current management guidelines and therapeutic approaches.

Main Results:

  • Key metabolic complications include lipodystrophy, dyslipidemia, insulin resistance, hyperlactatemia, and osteopenia.
  • Growth failure is a significant concern in this population.
  • Management strategies focus on monitoring, lifestyle modifications, and therapeutic adjustments.

Conclusions:

  • Effective management of metabolic complications is crucial for optimizing the long-term health and well-being of HIV-infected children.
  • Continued research is needed to refine treatment protocols and minimize long-term adverse effects.
  • A multidisciplinary approach is essential for comprehensive care.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
957
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K